TCL Archive Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho October 26, 2012
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
TCL Archive Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants March 11, 1983